CD8+DR+ T-Cells and C3 Complement Serum Concentration as Potential Biomarkers in Thrombotic Antiphospholipid Syndrome
Figure 1
Activated lymphocyte subsets. CD4+ and CD8+ activated T-cell subsets in APS patients and controls. APS: thrombotic APS; aPL: aPL positive controls without APS clinical criteria; HC: healthy controls; SLE: systemic lupus erythematosus controls. Subsets are expressed as percentages over total CD4+ or CD8+ T-cells.
